Similar articles for PMID: 26113896

Year	Number of Results
1995	4
1998	1
1999	2
2002	1
2004	5
2005	11
2006	11
2007	7
2008	9
2009	5
2010	7
2011	18
2012	12
2013	10
2014	7
2015	15
2016	8
2017	6
2018	4
2019	3
2020	6
2021	4
2022	2
2023	2
2024	0

1

Fetal nuchal translucency scan in Nigeria.

Oloyede OA, Abbey M, Oloyede AA, Nwachukwu O. Oloyede OA, et al. Pan Afr Med J. 2014 May 18;18:62. doi: 10.11604/pamj.2014.18.62.3291. eCollection 2014. Pan Afr Med J. 2014. PMID: 26113896 Free PMC article.

2

Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.

Soergel P, Pruggmayer M, Schwerdtfeger R, Muhlhaus K, Scharf A. Soergel P, et al. Fetal Diagn Ther. 2006;21(3):264-8. doi: 10.1159/000091353. Fetal Diagn Ther. 2006. PMID: 16601335

3

If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.

Marsk A, Grunewald C, Saltvedt S, Valentin L, Almström H. Marsk A, et al. Acta Obstet Gynecol Scand. 2006;85(5):534-8. doi: 10.1080/00016340500523701. Acta Obstet Gynecol Scand. 2006. PMID: 16752230 Free article.

4

Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.

Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z. Karadzov-Orlić N, et al. Srp Arh Celok Lek. 2012 Sep-Oct;140(9-10):606-11. Srp Arh Celok Lek. 2012. PMID: 23289277 Free article.

5

Prospective audit of a one-centre combined nuchal translucency and triple test programme for the detection of trisomy 21.

Babbur V, Lees CC, Goodburn SF, Morris N, Breeze AC, Hackett GA. Babbur V, et al. Prenat Diagn. 2005 Jun;25(6):465-9. doi: 10.1002/pd.1163. Prenat Diagn. 2005. PMID: 15966036

6

Prospective validation of first-trimester combined screening for trisomy 21.

Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH. Kagan KO, et al. Ultrasound Obstet Gynecol. 2009 Jul;34(1):14-8. doi: 10.1002/uog.6412. Ultrasound Obstet Gynecol. 2009. PMID: 19526452 Free article.

7

First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.

Prats P, Rodríguez I, Comas C, Puerto B. Prats P, et al. Prenat Diagn. 2012 Oct;32(10):927-32. doi: 10.1002/pd.3934. Epub 2012 Jul 3. Prenat Diagn. 2012. PMID: 22752980

8

Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.

Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. Falcon O, et al. Ultrasound Obstet Gynecol. 2006 Feb;27(2):151-5. doi: 10.1002/uog.2699. Ultrasound Obstet Gynecol. 2006. PMID: 16388509 Free article.

9

Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities.

Alexioy E, Alexioy E, Trakakis E, Kassanos D, Farmakidis G, Kondylios A, Laggas D, Salamalekis E, Florentin L, Kanavakis E, Basios G, Trompoukis P, Georgiadoy L, Panagiotopoulos T. Alexioy E, et al. J Matern Fetal Neonatal Med. 2009 Oct;22(10):857-62. doi: 10.1080/14767050902994572. J Matern Fetal Neonatal Med. 2009. PMID: 19521928

10

Comparison of first-trimester contingent screening strategies for Down syndrome.

Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, Lau TK. Sahota DS, et al. Ultrasound Obstet Gynecol. 2010 Mar;35(3):286-91. doi: 10.1002/uog.7549. Ultrasound Obstet Gynecol. 2010. PMID: 20052660 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

151 results

Results by year